Publications by authors named "Namit Rohant"
Article Synopsis
- The study examines how frailty and delirium affect in-hospital mortality and discharge outcomes for older adults hospitalized due to acute decompensated heart failure (ADHF).
- Data from over 3.5 million hospitalizations showed that both conditions significantly increase the risk of death and the likelihood of a non-home discharge.
- The most severe outcomes were observed in patients experiencing both high frailty and delirium, indicating a need for greater awareness and intervention strategies for these vulnerable patients.
The population worldwide is getting older as a result of advances in public health, medicine, and technology. Older individuals are living longer with a higher prevalence of subclinical and clinical cardiovascular disease (CVD). In 2010, the American Heart Association introduced a list of key prevention targets, known as "Life's Simple 7" to increase CVD-free survival, longevity, and quality of life.
View Article and Find Full Text PDFSarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic kidney disease, and cancer. Sarcopenia is associated with faster progression of cardiovascular diseases and higher risk of mortality, falls, and reduced quality of life, particularly among older adults. Although the pathophysiologic mechanisms are complex, the broad underlying cause of sarcopenia includes an imbalance between anabolic and catabolic muscle homeostasis with or without neuronal degeneration.
View Article and Find Full Text PDFOlder adults with cardiovascular disease (CVD) contend with deficits across multiple domains of health due to age-related physiological changes and the impact of CVD. Multimorbidity, polypharmacy, cognitive changes, and diminished functional capacity, along with changes in the social environment, result in complexity that makes provision of CVD care to older adults challenging. In this review, we first describe the history of geriatric cardiology, an orientation that acknowledges the unique needs of older adults with CVD.
View Article and Find Full Text PDFArticle Synopsis
- SGLT2 inhibitors (gliflozins) are gaining attention for effectively managing heart failure with reduced ejection fraction (HFrEF) and improving cardiovascular outcomes.
- They work by inhibiting SGLT2 channels in the kidneys, which helps lower blood glucose levels and has been linked to reduced hospitalizations and mortality in heart failure patients.
- Recent clinical trials have confirmed their cardiovascular safety and highlighted their benefits for both diabetic and non-diabetic patients with HFrEF, leading to an essential role in treatment protocols.
Introduction: Emergency physicians must be able to manage inappropriately firing defibrillators. Many physicians may not experience this high-risk, low-frequency patient presentation during residency. We created this simulation to increase residents' knowledge of basic defibrillator function and confidence in managing patients with malfunctioning defibrillators.
View Article and Find Full Text PDF